
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Autologous Adipose Derived Stem Cell
Therapeutic Area : Cardiology/Vascular Diseases
Study Phase : Phase I
Recipient : Arkansas Heart Hospital
Deal Size : Inapplicable
Deal Type : Inapplicable
Safety and Preliminary Efficacy of Adipose Derived Stem Cells and Low Frequency Ultrasound in PAD
Details : Autologous Adipose Derived Stem Cell is a Cell and Gene Therapy drug candidate, which is currently being evaluated in phase I clinical studies for the treatment of Peripheral Arterial Disease.
Product Name : Undisclosed
Product Type : Cell & Gene Therapy
Upfront Cash : Inapplicable
April 29, 2016
Lead Product(s) : Autologous Adipose Derived Stem Cell
Therapeutic Area : Cardiology/Vascular Diseases
Highest Development Status : Phase I
Recipient : Arkansas Heart Hospital
Deal Size : Inapplicable
Deal Type : Inapplicable
